Xyloketal B attenuates atherosclerotic plaque formation and endothelial dysfunction in apolipoprotein e deficient mice. - Wikidata - thesis-toulmin - TriplyDB

Xyloketal B attenuates atherosclerotic plaque formation and endothelial dysfunction in apolipoprotein e deficient mice.

Xyloketal B attenuates atherosclerotic plaque formation and endothelial dysfunction in apolipoprotein e deficient mice.

http://www.wikidata.org/entity/Q35548908

about

Xyloketal B alleviates cerebral infarction and neurologic deficits in a mouse stroke model by suppressing the ROS/TLR4/NF-κB inflammatory signaling pathway.Research Advances and Detection Methodologies for Microbe-Derived Acetylcholinesterase Inhibitors: A Systemic Review.

P2860

Q36383780-55734515-B633-40EF-8FF3-894CB4FFCEFC Q39104475-3897D067-FD40-47CF-90BA-D6C8B561D38D

P2860

Xyloketal B attenuates atherosclerotic plaque formation and endothelial dysfunction in apolipoprotein e deficient mice.

http://www.wikidata.org/entity/Q35548908

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Xyloketal B attenuates atheros ...... olipoprotein e deficient mice.

@ast

Xyloketal B attenuates atheros ...... olipoprotein e deficient mice.

@en

type

label

Xyloketal B attenuates atheros ...... olipoprotein e deficient mice.

@ast

Xyloketal B attenuates atheros ...... olipoprotein e deficient mice.

@en

prefLabel

Xyloketal B attenuates atheros ...... olipoprotein e deficient mice.

@ast

Xyloketal B attenuates atheros ...... olipoprotein e deficient mice.

@en

P1433

Q35548908-63CDEC24-8EE7-4E5F-9980-5F815D8C20D8

P1476

Q35548908-37EB03C6-33B8-46E3-821F-14E4632271D7

P2093

Q35548908-030D8F75-F27E-4E61-AE81-7A84E0F85DE5

Q35548908-171D0495-9D15-4A3E-AA5F-ECFA5312A7B8

Q35548908-3B7E9FAB-F28E-426C-A9EA-A6C1D3E78E8D

Q35548908-5D24881E-F2F9-4981-97C7-BEAA613C971E

Q35548908-6A75B5B1-B047-4C6C-B1C5-607058A272C3

Q35548908-76C30301-201E-491F-9F96-743EF79A016F

Q35548908-7A2E494C-AF02-49AC-B6D1-91908E712699

Q35548908-8C9EB519-EC14-45C3-87C5-E9875D4F989F

Q35548908-980F032F-0988-4C1C-8900-21063BFD84A2

Q35548908-9D16F947-36C7-4876-B87B-7D4C073EA907

P2860

Q35548908-0539FC32-316A-4139-85F2-08207B8A16AF

Q35548908-05AB4910-0C4E-4FDC-9F7C-8620E0395C12

Q35548908-0705DCD0-B854-4B6C-9D0C-377C7408A15B

Q35548908-078C1856-774A-45D5-9840-5C806877A8C9

Q35548908-09C0D056-D9F6-46E4-A0A2-6C1763E9EB58

Q35548908-09F4F794-A6BB-4B12-B094-3A372A288106

Q35548908-0DBAAFDE-A5EB-4213-B843-F0C60BB981CA

Q35548908-116BA4C1-5BE0-4C8A-B7E4-9DCAE978906B

Q35548908-14F127F4-550E-4068-A799-70F69F63BDC7

Q35548908-192F9D84-A555-40EC-A47A-2E86085E28C5

P304

Q35548908-78A3F020-1E20-445D-A124-90852B792720

P31

Q35548908-5CE96116-44EF-4076-BD8A-4A89605DF970

P356

Q35548908-10BDB09E-AF78-4FAD-B365-1D9A0BC8BA40

P433

Q35548908-FA17B74C-3F8D-444A-A0BB-BAD4833B94B0

P478

Q35548908-34409BA6-CA56-48B0-B860-DC94A909B2AD

P577

Q35548908-B10BDB0B-D3EB-40B6-A4AB-313F08C91784

P5875

Q35548908-2E13F33F-2D43-4C06-8460-5B9D915A19D8

P698

Q35548908-9BDDF653-107C-41C9-952B-2907E4FE1D1B

P921

Q35548908-6B78DFF8-3C77-41CA-82E6-166C491188BA

Q35548908-EAD92AB8-EBBC-4A9E-A478-1EFEC6E4EE7A

P932

Q35548908-DE2E8B02-7ED9-403E-BF39-C602E1EA95CA

P356

P1433

P1476

Xyloketal B attenuates atheros ...... olipoprotein e deficient mice.

@en

P2093

Bin Zhang

http://www.w3.org/2001/XMLSchema#string

Fang-Yun Sun

http://www.w3.org/2001/XMLSchema#string

Feng Yuan

http://www.w3.org/2001/XMLSchema#string

Guan-Lei Wang

http://www.w3.org/2001/XMLSchema#string

Hong-Mei Tan

http://www.w3.org/2001/XMLSchema#string

Hong-Shuo Sun

http://www.w3.org/2001/XMLSchema#string

Ji-Yan Pang

http://www.w3.org/2001/XMLSchema#string

Jie Li

http://www.w3.org/2001/XMLSchema#string

Jie Liu

http://www.w3.org/2001/XMLSchema#string

Li-Yan Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

The unfolding tale of PECAM-1

Nitric oxide synthases: regulation and function

Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria

An activator of mTOR inhibits oxLDL-induced autophagy and apoptosis in vascular endothelial cells and restricts atherosclerosis in apolipoprotein E⁻/⁻ mice.

Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction

Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity.

Mouse models of hyperlipidemia and atherosclerosis.

Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase.

Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress.

P304

2306-2326

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/MD13042306

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275046287

http://www.w3.org/2001/XMLSchema#string

P698

25874925

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

4413213

http://www.w3.org/2001/XMLSchema#string